The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic

Emma E. Seagle, Brendan R. Jackson, Shawn R. Lockhart, +17

Clinical Infectious Diseases

<i>In Vitro</i> Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with <i>FKS</i> Mutations

Natalie S. Nunnally, Kizee A. Etienne, David Angulo, +2

Antimicrobial Agents and Chemotherapy

Detection of TR ₃₄ /L98H <i>CYP51A</i> Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017

Elizabeth L. Berkow, Natalie S. Nunnally, Alex Bandea, +3

Antimicrobial Agents and Chemotherapy

In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents

Ourania Georgacopoulos, Natalie S. Nunnally, Eric M. Ransom, +4

Journal of Fungi

Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States

Kizee A. Etienne, Elizabeth L. Berkow, Lalitha Gade, +6

mBio

Antifungal activity of nikkomycin Z against <i>Candida auris</i>

Meghan L. Bentz, Natalie S. Nunnally, Shawn R. Lockhart, +2

Journal of Antimicrobial Chemotherapy

<i>In Vitro</i> Activity of the Novel Antifungal Olorofim against <i>Scedosporium</i> and <i>Lomentospora prolificans</i>

Ourania Georgacopoulos, Natalie S. Nunnally, Derek Law, +3

Microbiology Spectrum

Fatal Fungicide-Associated Triazole-Resistant <i>Aspergillus fumigatus</i> Infection, Pennsylvania, USA

Kennedy Bradley, Audrey Le-Mahajan, Beth Morris, +7

Emerging infectious diseases

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates

Elizabeth Misas, Emma E. Seagle, E. N. Jenkins, +14

Journal of Clinical Microbiology

Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease—Georgia, United States, 2017–2019

Jeremy A.W. Gold, Andrew Revis, Stepy Thomas, +17

Open Forum Infectious Diseases